
Article 1 
Lipid extract from Antarctic Krill Euphausia superba as specified in Annex I, may be placed on the market in the Community as a novel food ingredient for the uses and at the maximum levels as listed in Annex II.
Article 2 
The designation ‘lipid extract from the crustacean Antarctic Krill Euphausia superba’ shall be displayed on the labelling of the product as such or in the list of ingredients of foodstuffs containing it.
Article 3 
This Decision is addressed to Neptune Technologies & Bioressources Inc., 225 Promenade du Centropolis, Suite 200, Laval, Quebec H7T 0B3, Canada.
Done at Brussels, 12 October 2009.
For the Commission
Androulla VASSILIOU
Member of the Commission
ANNEX I
To produce lipid extract from Antarctic Krill Euphausia superba deep-frozen Antarctic krill is crushed and subjected to an extraction with acetone. Proteins and krill material are removed from the lipid extract by filtration. The acetone and residual water are removed by evaporation.


Test Specification
Saponification value Not more than 185 mg KOH/g
Peroxide value (PV) Not more than 0,2 meq O2/kg oil
Moisture and volatiles Not more than 0,9 %
Phospholipids Not more than 50 %
Trans-fatty acids Not more than 1 %
EPA (eicosapentaenoic acid) Not less than 15 %
DHA (docosahexaenoic acid) Not less than 7 %

ANNEX II

Use group Maximum content of combined DHA and EPA
Dairy products except milk-based drinks 200 mg/100 g or for cheese products 600 mg/100 g
Dairy analogues except drinks 200 mg/100 g or for analogues to cheese products 600 mg/100 g
Spreadable fat and dressings 600 mg/100 g
Breakfast cereals 500 mg/100 g
Food supplements 200 mg per daily dose as recommended by the manufacturer
Dietary foods for special medical purposes In accordance with the particular nutritional requirements of the persons for whom the products are intended
Foods intended for use in energy restricted diets for weight reduction 200 mg/meal replacement